retatrutide news today recency 3 New Phase data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats ADA 2026: Retatrutide Revolution

Why would you stop someone from using GLP-1 once started

The titration schedule over 16-20 weeks allows the body to adapt gradually

Phenomixs CEO Mark Bagnall spoke with Pharmaceutical Executive about this data and what the impact is on GLP-1 users

Schulman, MD, MPH, FASGE, an interventional and bariatric endoscopist and chief of endoscopy at Michigan Medicine, the ASAs guidance has led to cancellations and postponements of innumerable endoscopic procedures. We have required many patients to undergo general anesthesia who may otherwise have had their procedures performed under moderate sedation, which adds cost and clinical risk

The all-star option for GLP-1 users

Yet reports suggest some individuals are already seeking it through unofficial routes